LePu Medical

乐普医疗

Founded in 1999, LePu Medical Technology (Beijing) Co., Ltd. (stock code 300003) is a leading medical product industry group specializing in advanced cardiovascular interventional medical devices and equipment in China. Its business covers four major sectors: medical devices, pharmaceutical products, medical services, and new medical formats. The company’s main products include blood pressure monitors, oxygen concentrators, thermometers, and pharmaceuticals.

LePu Medical is one of the early enterprises in China engaged in the research, development, and manufacturing of cardiovascular interventional medical devices. It is also the National Heart Disease Implant Interventional Medical Device and Equipment Engineering Technology Research Center designated by the Ministry of Science and Technology of China. The company has dedicated itself to serving cardiovascular disease patients, focusing on research and innovation. It has achieved breakthroughs in areas such as cardiovascular stents, cardiac pacemakers, cardiovascular drugs, and medical artificial intelligence. LePu Medical has also undertaken various major national research projects, including projects from the National Development and Reform Commission, the Ministry of Science and Technology’s 863 Program, and the Science and Technology Support Program.

Presently, the company has evolved into an industry group specializing in advanced cardiovascular interventional medical devices and equipment, with business spanning medical devices, pharmaceutical products, medical services, and new medical formats.

LePu Medical adheres to a development principle of “pre-researching one generation, registering one generation, and producing and selling one generation.” It has moved from the era of coronary artery drug-eluting stents to the era of bioabsorbable medical devices and artificial AI intelligent medical devices. The company has developed internationally recognized products such as the second-generation bioabsorbable stent NeoVas, the new-generation vascular drug-eluting balloon catheter Vesselin, and advanced AI-ECG electrocardiogram analysis software systems. The company has a wide range of products, including coronary artery drug-eluting stents, balloons, pacemakers, occluders, heart valves, vascular imaging machines, IVD devices and diagnostic reagents, surgical instruments, AI electrocardiogram equipment, and home-use smart medical devices. In 2020, the company’s controlling subsidiary, Hefei Gaoxin Cardiovascular Disease Hospital (Gaoxin Heart Hospital), received approval from the Health Commission of Anhui Province to establish an “Internet hospital.”

In the future, the company will continue to develop a comprehensive industry platform covering the prevention, diagnosis, treatment, and rehabilitation of cardiovascular diseases. It aims to create a specialized ecosystem platform for “Cardiovascular Health + Anti-Tumor,” providing advanced products and high-quality services for more cardiovascular and cancer patients.

Best-selling Products from the LePu Medical Brand：